Can early-stage throat cancer be cured?

Written by Li Rui
Otolaryngology
Updated on March 09, 2025
00:00
00:00

If we are talking about early-stage laryngeal cancer, generally speaking, the cure rate is relatively high. The main treatment methods for early-stage laryngeal cancer are primarily surgical, although radiation therapy can also be considered for some patients. However, specific treatments still need to be tailored according to the patient's own condition and the pathological staging and typing. If the cancer is well-differentiated, the treatment outcomes are generally better. If it is poorly differentiated or moderately differentiated, even though it is early-stage laryngeal cancer, the cure rate is relatively lower, especially within the first two years and the first five years. If a five-year survival rate is achieved without evident recurrences or metastases, this is considered a standard for clinical cure. However, regular follow-ups are still necessary due to the potential risk of recurrence.

Other Voices

doctor image
home-news-image
Written by Li Rui
Otolaryngology
50sec home-news-image

Is the embryonic antigen high in throat cancer?

Throat cancer is a relatively common otolaryngology disease and also belongs to a common type of head and neck malignant tumor. Generally, the carcinoembryonic antigen does not show obvious elevation because, currently, there are no characteristic tumor markers for throat cancer. Diagnosis is mainly based on the clinical experience of doctors, combined with laryngoscopic examination and CT scan of the throat area. For patients with throat cancer, it is advised to promptly visit an otolaryngology clinic after the onset of the disease and undergo related auxiliary examinations to clarify the specific extent of the condition. Common treatment methods include surgery, radiotherapy, and chemotherapy. A targeted treatment plan should be chosen based on the clinical staging of the patient.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 1sec home-news-image

Does CEA increase in throat cancer?

In the blood tests of some laryngeal cancer patients, an increase in the CEA index may be observed, but most laryngeal cancer patients do not exhibit abnormal CEA levels. This is because laryngeal cancer is a common malignant tumor in the head and neck region, and currently, there are no specific tumor markers clinically for laryngeal cancer. CEA, also known as carcinoembryonic antigen, is a tumor marker that is most often elevated in the bodies of patients with malignant tumors. Clinically, an increase in the CEA level is commonly seen in malignant tumors of the gastrointestinal tract, thoracic malignancies, malignancies in the female urogenital system, and some tumors in the male urogenital system. However, in patients with head and neck malignancies, this marker is not commonly elevated.

doctor image
home-news-image
Written by Li Rui
Otolaryngology
45sec home-news-image

Can throat cancer be cured?

Throat cancer is a relatively common type of head and neck malignancy with a high clinical incidence. Most patients require surgical treatment, and some need comprehensive treatment combining radiotherapy and chemotherapy. Generally, patients diagnosed in the early stages have better treatment outcomes and higher five-year survival rates. Typically, achieving a five-year survival rate after standardized surgery or radiotherapy and chemotherapy is considered a clinical cure. However, the proportion of patients in the middle to late stages achieving this is relatively low. Therefore, regular follow-ups are necessary to monitor the recovery process, regardless of the stage or type of the disease.

doctor image
home-news-image
Written by Deng Bang Yu
Otolaryngology
42sec home-news-image

Can throat cancer be contagious?

Laryngeal cancer is a malignant tumor of the larynx, which is clinically primarily squamous cell carcinoma and belongs to epithelial malignancies. Generally, epithelial malignancies are not contagious. However, laryngeal cancer may sometimes be related to certain viral infections, such as papillomatosis, which might be contagious. This is an aspect of its etiology, but laryngeal cancer itself is not contagious. In summary, laryngeal cancer is not contagious. It is a malignant tumor disease, and its clinical treatment mainly involves surgical intervention, which can be supplemented with radiation therapy and other treatments.

doctor image
home-news-image
Written by Liu Liang
Oncology
44sec home-news-image

The difference between esophageal cancer and laryngeal cancer

Esophageal cancer and laryngeal cancer are both malignant tumors. Esophageal cancer refers to the malignant tumor occurring in the esophagus, while laryngeal cancer refers to the malignant tumor occurring in the larynx. Therefore, their tumor locations are different. The pathology of both is generally squamous cell carcinoma. The main symptom of esophageal cancer is obstructed eating; patients will feel difficulty swallowing, obstruction, and worsening of these symptoms as they eat. The primary symptom of laryngeal cancer is typically a hoarse voice, which distinguishes the symptoms of the two cancers.